Invention Publication
- Patent Title: PAC1 ANTIBODIES AND USES THEREOF
-
Application No.: US18545688Application Date: 2023-12-19
-
Publication No.: US20240150448A1Publication Date: 2024-05-09
- Inventor: Neeraj Jagdish AGRAWAL , Irwin CHEN , Su CHONG , Bryna FUCHSLOCHER , Kevin GRAHAM , Agnes Eva HAMBURGER , Mark Leo MICHAELS , Christopher MOHR , Derek E. PIPER , Kenneth William WALKER , Zhulun WANG , Cen XU
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- The original application number of the division: US16246326 2019.01.11
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K38/22 ; A61P25/06 ; C07K16/28
Abstract:
The present invention relates to neutralizing antibodies of the human pituitary adenylate cyclase activating polypeptide type I receptor (PAC1) and pharmaceutical compositions comprising such antibodies. Methods of treating or preventing headache conditions, such as migraine and cluster headache, using the neutralizing antibodies are also described.
Information query
